MRC1 and neoplasm: Thus, MMR deficiency not only increases tumor mutational burden (TMB) as a result of errors in DNA repair or translocations that produce tumor neoantigens, but also strongly activates inflammation in the tumor microenvironment, likely triggered by sensing cytosolic gDNA.